Get started
PharmAla Biotech Holdings Inc.PharmAla Biotech Holdings Inc.PharmAla Biotech Holdings Inc.

PharmAla Biotech Holdings Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

MDXXF chart

Key stats

Market capitalization
‪11.54 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0053USD
Net income (FY)
‪−576.91 K‬USD
Revenue (FY)
‪393.58 K‬USD
Shares float
‪79.45 M‬
Beta (1Y)
0.70

About PHARMALA BIOTECH HOLDINGS INC.

Sector
Health Technology
CEO
Nicholas Kadysh
Headquarters
Toronto
Website
pharmala.ca
FIGI
BBG01GHNMNF3
PharmAla Biotech Holdings, Inc. is a biotechnology company, which engages in the research, development, and manufacturing of MDXX class molecules, including MDMA. It also provides manufacturing of active pharmaceutical ingredient (API) and drug product formulation. The company was founded on January 12, 2021 and is headquartered in Toronto, Canada.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MDXXF is 0.1159 USD — it has decreased by 15.83% in the past 24 hours. Watch PharmAla Biotech Holdings Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange PharmAla Biotech Holdings Inc. stocks are traded under the ticker MDXXF.
MDXXF stock has fallen by 28.90% compared to the previous week, the month change is a 24.74% fall, over the last year PharmAla Biotech Holdings Inc. has showed a 61.98% decrease.
MDXXF reached its all-time high on Jun 29, 2023 with the price of 0.3600 USD, and its all-time low was 0.0536 USD and was reached on Oct 5, 2023. View more price dynamics on MDXXF chart.
See other stocks reaching their highest and lowest prices.
MDXXF stock is 18.81% volatile and has beta coefficient of 0.70. Track PharmAla Biotech Holdings Inc. stock price on the chart and check out the list of the most volatile stocks — is PharmAla Biotech Holdings Inc. there?
Yes, you can track PharmAla Biotech Holdings Inc. financials in yearly and quarterly reports right on TradingView.
MDXXF net income for the last quarter is ‪−163.87 K‬ USD, while the quarter before that showed ‪26.88 K‬ USD of net income which accounts for −709.56% change. Track more PharmAla Biotech Holdings Inc. financial stats to get the full picture.
No, MDXXF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PharmAla Biotech Holdings Inc. EBITDA is ‪−312.38 K‬ USD, and current EBITDA margin is −136.66%. See more stats in PharmAla Biotech Holdings Inc. financial statements.
Like other stocks, MDXXF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PharmAla Biotech Holdings Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PharmAla Biotech Holdings Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PharmAla Biotech Holdings Inc. stock shows the neutral signal. See more of PharmAla Biotech Holdings Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.